Literature DB >> 19847139

Evidence for tissue factor expression in aortic valves in patients with aortic stenosis.

Joanna Natorska1, Grzegorz Marek, Marta Hlawaty, Dorota Sobczyk, Jerzy Sadowski, Wiesława Tracz, Anetta Undas.   

Abstract

INTRODUCTION: The role of blood coagulation in the pathogenesis of aortic stenosis (AS) is unknown. Recently, tissue factor (TF) expression in stenotic aortic valves has been reported in animal model.
OBJECTIVES: The aim of the study was to investigate TF expression in valve leaflets obtained from AS patients and to determine its associations with circulating coagulation markers and echocardiographic variables. PATIENTS AND METHODS: We studied 20 patients (10 men, 10 women) with dominant AS (age 62.9 +/-9.6, years, mean gradient 43.62 +/-14.62 mmHg), and 20 well-matched patients with dominant aortic insufficiency (AI) undergoing elective aortic valve replacement. Immunofluorescence was measured on decalcified leaflets using antibodies against human TF and macrophages. Prothrombin fragment 1+2 (F1+2) and circulating TF were determined in plasma prior to surgery.
RESULTS: AS valves were characterized by an increased (all, p <0.001) percentage of TF-positive (24.6%) and macrophage-containing (27.3%) areas detected mainly on the aortic side of the leaflets, compared with AI valves (6.3% and 7.4%, respectively). Patients with AS had elevated F1+2 (262.1 +/-27.8 pmol/l, p <0.001) and plasma TF (median 131.8, interquartile range [91.42-310.56] pg/ml, p = 0.018) compared with AI subjects (136.1 +/-11.9 pmol/l, 65.38 [49.51-87.81] pg/ml, respectively). Percentage of TF-positive areas correlated with plasma TF (r = 0.68, p <0.0001), but not with F1+2. Maximum transvalvular gradient >75 mmHg, but not the aortic valve area, showed associations with percentage of TF-positive areas (r = 0.88, p = 0.0039).
CONCLUSIONS: This study is the first full-length report demonstrating the presence of TF associated with macrophage infiltration in human aortic valve leaflets in AS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19847139

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  6 in total

1.  Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation.

Authors:  Joanna Luszczak; Anetta Undas; Matthew Gissel; Maria Olszowska; Saulius Butenas
Journal:  Blood Coagul Fibrinolysis       Date:  2011-09       Impact factor: 1.276

2.  Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis.

Authors:  Rihab Bouchareb; Marie-Chloé Boulanger; Lionel Tastet; Ghada Mkannez; Mohamed J Nsaibia; Fayez Hadji; Abdellaziz Dahou; Younes Messadeq; Benoit J Arsenault; Philippe Pibarot; Yohan Bossé; André Marette; Patrick Mathieu
Journal:  Eur Heart J       Date:  2019-05-01       Impact factor: 29.983

Review 3.  Inflammatory and Biomechanical Drivers of Endothelial-Interstitial Interactions in Calcific Aortic Valve Disease.

Authors:  Katherine Driscoll; Alexander D Cruz; Jonathan T Butcher
Journal:  Circ Res       Date:  2021-04-29       Impact factor: 17.367

4.  Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves?

Authors:  Joanna Natorska; Ewa Wypasek; Grzegorz Grudzień; Dorota Sobczyk; Grzegorz Marek; Grzegorz Filip; Jerzy Sadowski; Anetta Undas
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

5.  Diabetes Is Associated With Rapid Progression of Aortic Stenosis: A Single-Center Retrospective Cohort Study.

Authors:  Kangning Han; Dongmei Shi; Lixia Yang; Meng Xie; Rongrong Zhong; Zhijian Wang; Fei Gao; Xiaoteng Ma; Yujie Zhou
Journal:  Front Cardiovasc Med       Date:  2022-02-23

Review 6.  Towards Personalized Therapy of Aortic Stenosis.

Authors:  Piotr Mazur; Magdalena Kopytek; Michał Ząbczyk; Anetta Undas; Joanna Natorska
Journal:  J Pers Med       Date:  2021-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.